市场调查报告书
商品编码
1548173
全球药物发现服务市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Drug Discovery Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球药物发现服务市场需求预计将从 2023 年的 251.5 亿美元达到 2032 年近 863.4 亿美元的市场规模,2024-2032 年研究期间复合年增长率为 14.69%。
药物发现服务涉及识别和开发新药物化合物的各种专门活动。这些服务包括目标识别、先导化合物优化、临床前测试和早期临床试验。这些服务由合约研究组织 (CRO) 提供,这些组织提供药物开发各个方面的专业知识,包括分子建模、高通量筛选和生物资讯学。这些服务旨在加速发现过程、降低成本并提高药物开发成功的可能性。透过提供从初始研究到早期临床阶段的全面支持,这些服务在将新疗法推向市场方面发挥着至关重要的作用。对创新药物的需求不断增长以及药物开发过程日益复杂,推动了这些服务的市场。
药物发现服务市场是由药物开发日益复杂性所推动的,这需要专门的服务来管理发现过程的各个阶段。随着製药公司在开发新疗法方面面临越来越多的挑战,他们越来越依赖药物发现服务来提供专业知识、先进技术和简化的流程,以提高效率和效果。技术进步为市场提供了重大机会。人工智慧和机器学习等创新能够更快、更准确地识别潜在候选药物,从而改变药物发现。这些技术促进了预测建模、资料分析和虚拟筛选,显着加快了发现过程并提高了成功率。
慢性病的流行和对新疗法的需求推动了市场的成长。随着癌症、心血管疾病和神经退化性疾病等疾病的全球负担增加,对创新疗法的需求不断增长。药物发现服务透过支持新疗法和疗法的开发,在满足这一需求方面发挥着至关重要的作用。此外,将药物发现活动外包给专业 CRO 的趋势创造了更多机会。製药公司寻求透过与提供专业知识和先进技术的 CRO 合作来降低成本并提高专注度。然而,这些服务的高成本和漫长的开发时间可能会阻碍市场成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球药物发现服务市场的每个细分市场进行包容性评估。药物发现服务业的成长和趋势为这项研究提供了整体方法。
药物发现服务市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域展望,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲药物发现服务市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物发现服务市场的主要参与者包括 Charles River Laboratories International Inc.、Thermo Fisher Scientific Inc.、Wuxi AppTec、Eurofins Scientific 等。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Drug Discovery Services Market is presumed to reach the market size of nearly USD 86.34 Billion by 2032 from USD 25.15 Billion in 2023 with a CAGR of 14.69% under the study period 2024-2032.
Drug discovery services involve various specialized activities to identify and develop new pharmaceutical compounds. These services include target identification, hit-to-lead optimization, preclinical testing, and early-phase clinical trials. These services are provided by contract research organizations (CROs), which offer expertise in various aspects of drug development, including molecular modeling, high-throughput screening, and bioinformatics. These services aim to accelerate the discovery process, reduce costs, and improve the likelihood of successful drug development. By providing comprehensive support from initial research through early clinical stages, these services play a crucial role in bringing new therapies to market. The increasing demand for innovative drugs and the growing complexity of drug development processes drive the market for these services.
The drug discovery services market is driven by the increasing complexity of drug development, which necessitates specialized services to manage various stages of the discovery process. As pharmaceutical companies face growing challenges in developing new therapies, they increasingly rely on drug discovery services to provide expertise, advanced technologies, and streamlined processes that enhance efficiency and effectiveness. Technological advancements offer significant opportunities within the market. Innovations such as artificial intelligence & machine learning are transforming drug discovery by enabling faster and more accurate identification of potential drug candidates. These technologies facilitate predictive modeling, data analysis, and virtual screening, significantly accelerating the discovery process and improving success rates.
The propelling prevalence of chronic diseases and the need for new treatments drive market growth. As the global burden of conditions such as cancer, cardiovascular diseases, and neurodegenerative disorders increases, there is a growing demand for innovative therapies. Drug discovery services play a crucial role in addressing this need by supporting the development of novel treatments and therapies. Additionally, the trend towards outsourcing drug discovery activities to specialized CROs creates further opportunities. Pharmaceutical companies seek to reduce costs and improve focus by partnering with CROs that offer specialized expertise and advanced technologies. However, the high cost of these services and the lengthy development timelines can hamper market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Drug Discovery Services. The growth and trends of Drug Discovery Services industry provide a holistic approach to this study.
This section of the Drug Discovery Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Drug Discovery Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Drug Discovery Services market include Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Wuxi AppTec, Eurofins Scientific, . This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.